Alteration in ATR protein level does not account for the inherent radiosensitivity of HPV-positive head and neck squamous cell carcinoma

被引:0
|
作者
Kohl, Sibylla [1 ]
Subtil, Florentine S. B. [1 ]
Climenti, Vanessa [1 ]
Anees, Houmam [1 ]
Parplys, Ann C. [1 ]
Engenhart-Cabillic, Rita [1 ,2 ]
Adeberg, Sebastian [1 ,2 ]
Dikomey, Ekkehard [1 ,3 ]
Theiss, Ulrike [1 ,2 ]
机构
[1] Philipps Univ Marburg, Dept Radiotherapy & Radiat Oncol, Marburg, Germany
[2] Marburg Univ Hosp, Marburg Ion Beam Therapy Ctr MIT, Dept Radiotherapy & Radiat Oncol, Marburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany
来源
TRANSLATIONAL ONCOLOGY | 2025年 / 55卷
关键词
Head and neck squamous cell carcinoma; Human papilloma virus; ATR; Radiosensitivity; DSB repair; HR; MEDIATED RADIOSENSITIZATION; CANCER; INHIBITION; LINES; OLAPARIB; AZD6738;
D O I
10.1016/j.tranon.2025.102359
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Human papilloma virus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) cells are highly radiosensitive resulting from an elevated number of DNA double-strand breaks (DSB) remaining after irradiation. Partially this effect is due to a defective homologous recombination (HR). HPV-positive cells also show pronounced instability of chromosome 3, which codes for the kinase ataxia-telangiectasia and Rad3-related (ATR) protein, a central player of HR. If there is a contribution of ATR to the radiosensitivity of HPV-positive cells remains unclear, and this in-vitro study tested a functional involvement of ATR expression. Methods: The study was performed with six HPV-negative and six HPV-positive HNSCC cell lines. Gene copy number and gene expression were determined via qRT-PCR, protein expression by Western Blot. Response of cells towards irradiation in dependence of ATR expression was tested after siRNA Knock-down (ATRKD). Clonogenic survival after photon irradiation was evaluated by colony formation assay and DSBs were visualized by gamma H2AX/53BP1 co-staining. Results: ATR gene copy number and expression were not altered. Protein level was almost two-fold lower in HPVpositive compared to HPV-negative cells, but fully functional as observed by active phosphorylation in response towards irradiation. ATRKD resulted in a further increase in both, radiosensitivity as well as number of residual DSBs, but only for HPV-positive cells. Conclusion: Since the effect of ATRKD was compensated in HPV-negative but not in HPV-positive cells, these data revealed that the two-fold lower level of ATR in HPV-positive cells does not account for their enhanced inherent radiosensitivity, but acts additive to irradiation.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
    Wu, Qingqing
    Shao, Tingru
    Huang, Guangzhao
    Zheng, Zenan
    Jiang, Yingtong
    Zeng, Weisen
    Lv, Xiaozhi
    BIOMOLECULES, 2022, 12 (10)
  • [42] DNMT1 Enhances the Radiosensitivity of HPV-Positive Head and Neck Squamous Cell Carcinomas via Downregulating SMG1
    Zhang, Chunlin
    Mi, Jiaoping
    Deng, Yuan
    Deng, Zeyi
    Long, Dan
    Liu, Zhaohui
    ONCOTARGETS AND THERAPY, 2020, 13 : 4201 - 4211
  • [43] Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-positive versus HPV-negative head and neck squamous cell carcinoma
    Partlova, Simona
    Boucek, Jan
    Tachezy, Ruth
    Spisek, Radek
    Fialova, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] ATR inhibition sensitizes HPV- and HPV+ head and neck squamous cell carcinoma to cisplatin
    Leonard, Brandon C.
    Lee, Eliot D.
    Bhola, Neil E.
    Li, Hua
    Sogaard, Kristian K.
    Bakkenist, Christopher J.
    Grandis, Jennifer R.
    Johnson, Daniel E.
    ORAL ONCOLOGY, 2019, 95 : 35 - 42
  • [45] Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas
    Dok, Rueveyda
    Bamps, Marieke
    Glorieux, Mary
    Zhao, Peihua
    Sablina, Anna
    Nuyts, Sandra
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (04) : 1075 - 1085
  • [46] Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines
    Knuth, Jennifer
    Sharma, Shachi J.
    Wuerdemann, Nora
    Holler, Claudia
    Garvalov, Boyan K.
    Acker, Till
    Wittekindt, Claus
    Wagner, Steffen
    Klussmann, Jens P.
    ONCOTARGET, 2017, 8 (52): : 89681 - 89691
  • [47] Subgroups of HPV-positive and HPV-negative head and neck squamous cell carcinoma differing in global copy number changes and prognosis
    Schneider, L.
    Selmansberger, M.
    Schuettrumpf, L.
    Maihoefer, C.
    Pflugradt, U.
    Kirchner, T.
    Woischke, C.
    Belka, C.
    Zitzelsberger, H.
    Ganswindt, U.
    Unger, K.
    Hess, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S149 - S149
  • [48] Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma
    Deeken, John F.
    Newkirk, Kenneth
    Harter, K. William
    Marshall, M. Blair
    Banovac, Filip
    Johnson, Lynt
    Wang, Hongkun
    Wang, Yiru
    Zhuang, Tingting
    Jay, Ann K.
    Berkowitz, Frank
    Esposito, Giuseppe
    Kallakury, Bhaskar
    Davidson, Bruce
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (05): : 630 - 635
  • [49] Pyroptosis patterns influence the clinical outcome and immune microenvironment characterization in HPV-positive head and neck squamous cell carcinoma
    Doudou Li
    Dong Ma
    Yuxia Hou
    Infectious Agents and Cancer, 18
  • [50] High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
    Alexandra Scheiflinger
    Sega Al-Gboore
    Bernhard J. Jank
    Faris Brkic
    Lorenz Kadletz-Wanke
    Lukas Kenner
    Gregor Heiduschka
    Julia Schnoell
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10675 - 10683